Skip to content

GCRI · Labs · Foundations

Experimental research methods and testbeds: the foundations of a discipline

Experimental research methods and testbeds is the discipline of designing studies, trials and controlled test environments that produce evidence others can check and use. This foundational guide explains design, registration, reproducibility, open data, testbeds, sandboxes, AI in research and the instruments that govern them.

As of
16 November 2026
읽기
19 minutes
증거
25 sources, cited in order
방법
A synthesis of foundational studies on research reliability and reproducibility with current public evidence: UN SDG indicators on research capacity, UNCTAD and WIPO reports, WHO and national trial registries, EU law on clinical trials and AI, NIST and NASA frameworks, and research integrity codes.
데이터
Every value in the article comes from a published source listed in the references. Capacity figures come from the UN Statistics Division and UNCTAD; registry counts from the public ClinicalTrials.gov API, read on 16 November 2026; replication evidence from the cited studies.
NEXUS TWIN · WF-1 · CLOUDSEED f328a6b4G08.PILLARxyzSCHEMATIC · CLOUDAGENT TRACK
WF-1 · cloud Schematic wireframe twin (cloud, compute and data systems). An illustration, not data.

방법과 근거

질문
What does the discipline of experimental research methods and testbeds study, what does the evidence say about the reliability of research, and which instruments govern experiments, trials, testbeds and sandboxes?
접근 방식
A synthesis of foundational studies on research reliability and reproducibility with current public evidence: UN SDG indicators on research capacity, UNCTAD and WIPO reports, WHO and national trial registries, EU law on clinical trials and AI, NIST and NASA frameworks, and research integrity codes.
증거
25 sources, cited in order and listed under References
Data availability
Every value in the article comes from a published source listed in the references. Capacity figures come from the UN Statistics Division and UNCTAD; registry counts from the public ClinicalTrials.gov API, read on 16 November 2026; replication evidence from the cited studies.
한계
Replication rates differ widely across fields, and the best-known projects come from a few disciplines. Capacity indicators measure inputs rather than results. Registry counts include studies of very different quality. The article is not ethical or regulatory advice for any study.

01정의

What experimental research methods and testbeds mean

One discipline that joins the design of trustworthy studies with the controlled environments where new ideas are tested.

Experimental research methods and testbeds is the discipline of designing studies, trials and controlled test environments that produce reliable evidence about what works, what fails and why. It covers the protocols that fix a question and method in advance, the laboratories and field sites where tests run, the data and code that let others check results, and the governance that keeps experiments safe and honest.

An experiment changes one or more factors on purpose and measures what follows, so that cause can be separated from coincidence. A protocol is the written plan of a study: its question, design, sample, measures and analysis, set down before data are collected. A testbed is a controlled environment, physical, digital or hybrid, where a technology, policy or service can be tried at realistic scale before it is released.

Reliability is the core concern. The National Academies of Sciences, Engineering, and Medicine describe repeating research as one of the pathways by which the scientific community confirms a new discovery, and set out shared definitions of reproducibility and replicability across fields 7. Reproducibility means getting the same result from the same data and code; replicability means getting consistent results from a new study of the same question.

The discipline matters for risk because decisions about hazards, technologies and policies rest on evidence. A flood model, a vaccine trial, an AI system or a new early warning service is only as trustworthy as the tests behind it. This article is the hub of the Labs platform and links to a foundational article on each of its eight topics.

02Stakes

Why experimental methods matter now

More research than ever, uneven capacity, and a measured reliability problem.

Research is expanding. The UN reports that global investment in research and development grew by 5.1 per cent a year from 2015 to 2022, and that the share of global GDP invested in it rose from 1.72 to 1.95 per cent 1. The research workforce grew from 1,137 to 1,420 researchers per million people over the same period 1.

Capacity is uneven. Sub-Saharan Africa remained at 91 researchers per million people 1. UN Trade and Development (UNCTAD) reports that just 100 firms, mainly in the United States and China, account for 40 per cent of global corporate research and development spending 8. Where testing capacity is thin, countries depend on evidence produced elsewhere, for other conditions.

Reliability is a measured problem. The Open Science Collaboration repeated 100 experiments from three psychology journals; 36 per cent of the replications had statistically significant results, against 97 per cent of the original studies 2.

New tools raise the stakes. UNCTAD expects artificial intelligence to reach $4.8 trillion in market value by 2033 8. Where such tools enter research, methods that make evidence transparent and testable matter as much as before.

03설계

Designing an experiment

Questions, controls, randomisation, samples and pre-specified analysis.

A good experiment starts with a precise question and a comparison. It asks what happens when one factor changes and the rest stay the same. A control group, which does not receive the change, shows what would have happened anyway; random assignment to groups makes it unlikely that hidden differences explain the result.

Sample size and effect size decide what a study can detect. John Ioannidis showed in PLoS Medicine in 2005 that a research finding is less likely to be true when studies are small, effects are small, many relationships are tested with little preselection, and designs, definitions, outcomes and analyses are flexible 9.

Flexibility is the hidden risk. If researchers can choose after seeing the data which outcomes to report or which analysis to run, chance results become easy to find. Writing the analysis plan down in advance, and reporting every pre-specified outcome, closes that door.

Not every question allows a randomised experiment. Natural experiments, matched comparisons and quasi-experimental designs estimate causal effects from observational data when assignment cannot be controlled. The Labs platform pages on causal inference and probability and statistics explain these methods, and the topic on research protocols covers how plans are written and reviewed.

04등록

Registration and pre-registration

Fixing the plan before the results are known.

Registration makes a study visible before it reports. The Declaration of Helsinki, last amended by the World Medical Association in October 2024, states that medical research involving human participants must be registered in a publicly accessible database before the first participant is recruited 3.

A global system supports this. The World Health Organization (WHO) runs the International Clinical Trials Registry Platform, which brings together a network of registries, registry criteria and a common data set 10. The WHO Trial Registration Data Set currently has 24 items, the minimum information a register must hold for a trial to count as fully registered 11.

Registries are large. On 16 November 2026, ClinicalTrials.gov, run by the U.S. National Library of Medicine, listed 612,025 registered studies 12. In the European Union, Regulation (EU) No 536/2014 requires clinical trials to be registered in a public EU database before they start 13.

Pre-registration extends the idea beyond medicine. Researchers in any field can register a protocol and analysis plan before collecting data. The Registered Reports format goes further: journals review the question and methods before results exist, and more than 300 journals now offer it 4.

05신뢰성

Reproducibility, replication and negative results

Why findings fail to repeat, and what the research community is doing about it.

Failures to replicate have several causes. Small samples and flexible analysis produce false positives 9. Selective publication hides null results, so the published record overstates effects. Incomplete methods sections, missing data and unshared code stop others from checking what was done.

The evidence is now substantial. The Open Science Collaboration found that 36 per cent of 100 replications of psychology studies had statistically significant results, against 97 per cent of the originals 2. The National Academies' 2019 consensus report examined reproducibility and replicability across science and engineering and set common definitions 7.

Remedies are well described. A manifesto for reproducible science, published in Nature Human Behaviour in 2017, proposes measures across methods, reporting, reproducibility, evaluation and incentives 14. They include pre-registration, open data and code, larger collaborative studies, and rewards for replication. The National Institutes of Health describes rigor in designing and performing research, and the ability to reproduce findings, as two cornerstones of the advancement of science, and gives applicants guidance on rigor and transparency 15.

Negative results have value. A well-designed study that finds no effect saves others from repeating a dead end and corrects the published record. The topic on reproducibility and negative results explains how to report and publish them.

06데이터

Open data, code and FAIR principles

Making evidence findable and reusable.

Evidence that cannot be found or read cannot be checked. The FAIR Guiding Principles, published in Scientific Data in 2016, ask that research data be Findable, Accessible, Interoperable and Reusable, by people and by machines 16. The GO FAIR initiative maintains guidance on applying each principle 17.

Funders now require it. The U.S. National Institutes of Health Data Management and Sharing Policy, effective 25 January 2023, requires plans for managing and sharing scientific data 18.

Openness has limits that methods must respect. Personal data, sensitive locations, security-relevant results and commercial information may need controlled access rather than open release. Good practice states what is shared, under which licence, and why anything is withheld.

Code matters as much as data. Analyses run in scripts that others can execute, with fixed software versions and documented random seeds, can be reproduced years later. The Labs platform page on uncertainty quantification and model validation covers how models are checked against data.

07테스트베드

Testbeds: from the laboratory to the field

Controlled environments where technologies and services are tried at realistic scale.

A testbed sits between the laboratory and real use. It recreates enough of the real world, such as a power grid segment, a stretch of road, a hospital ward or a simulated city, to show how a technology behaves under realistic conditions while keeping risks contained and measured.

Maturity is measured in steps. The National Aeronautics and Space Administration (NASA) defines Technology Readiness Levels as a measurement system for the maturity of a technology, with nine levels from TRL 1 to TRL 9 5. Testbeds typically serve the middle levels, where a prototype must prove itself in a relevant environment.

Large shared facilities lower the cost of testing. The European Commission and Member States co-fund Sectorial AI Testing and Experimentation Facilities, specialised large-scale reference sites open to technology providers across Europe to test AI solutions at scale 19. Sectors include agrifood 19.

Field and laboratory tests answer different questions. A laboratory isolates a mechanism; a field trial shows whether it holds among real people, weather and institutions. The topic on field and lab testbeds explains how the two are combined, and the page on systems engineering covers how complex systems are tested before deployment.

08Sandboxes

Sandboxes and experimental governance

Supervised experiments with rules as well as technologies.

A regulatory sandbox lets firms or public bodies test something new under a regulator's supervision, with safeguards and an agreed scope. The United Kingdom's Financial Conduct Authority runs a Regulatory Sandbox for firms that want to test new products live in the market with real consumers 20.

European law now requires sandboxes for AI. The Artificial Intelligence Act provides that each Member State establish at least one AI regulatory sandbox at national level, a controlled environment for developing and testing AI systems before they are placed on the market 6. Sandboxes may be physical, digital or hybrid 6.

The same Act separates research from deployment. AI systems developed and put into service for the sole purpose of scientific research and development are excluded from its scope, while research must still follow recognised ethical and professional standards 6.

Sandboxes are experiments in governance as much as in technology: they let regulators learn what rules a new product needs. The Global Risks Forum topic on experimental governance follows how such arrangements are designed and evaluated.

09AI

과학 워크플로의 AI

Faster analysis and design, with new demands on validation.

Artificial intelligence now runs through many experiments. It screens candidate molecules, designs experiments, controls instruments, cleans data and drafts analyses. Each use can speed discovery, and each adds a component whose behaviour must itself be tested.

Risk frameworks apply to research tools as well as products. The U.S. National Institute of Standards and Technology (NIST) released its AI Risk Management Framework on 26 January 2023 to help organisations manage the risks of AI systems 21. Its approach of mapping, measuring and managing risk applies to AI used inside a laboratory.

Validation is the key discipline. A model trained on one data set may fail on another; an automated analysis may hide choices that a human would have reported. Good practice records model versions, training data and prompts, tests outputs against known cases, and keeps a human accountable for conclusions.

Capacity is concentrated. UNCTAD reports that 118 countries lack representation in AI governance 8. The topic on AI and scientific workflows covers how AI is validated in research, and the Labs page on artificial intelligence and machine learning explains the methods.

10검증

Uncertainty, models and validation

Testing models against evidence, and saying how sure a result is.

Many experiments in risk science run on models rather than test tubes. A flood model, an epidemic model or a loss model is itself a hypothesis about how a system behaves, and it needs the same discipline as a laboratory experiment: a stated question, a plan for testing it, and a record that others can check.

Validation compares model outputs with observations the model did not see. A model tuned on one period should be tested on another, and a model built for one region should be tested before it is used in a second. Where data are scarce, sensitivity analysis shows which assumptions drive the result, and an ensemble of models shows how far reasonable choices can move it.

Every result should carry its uncertainty. A single number without a range invites false confidence; a range without an explanation invites confusion. Good reports say what was measured, how precise it is, which sources of error were not quantified, and how the conclusion would change if a key assumption were wrong.

The same logic applies to technologies tested in testbeds. A test shows how a system behaved under the conditions tried, not under every condition it will meet. The Labs page on uncertainty quantification and model validation covers these methods, and the Global Risks Alliance topic on extreme value methods shows how rare events are modelled when data are thin.

11역량

Building research and testing capacity

Who can run experiments, and how the gaps can narrow.

Experimental capacity is people, equipment, data and institutions together. The UN reports that the world had 1,420 researchers per million people in 2022, against 91 in sub-Saharan Africa 1. Countries with few researchers and little laboratory infrastructure rely on evidence produced elsewhere, which may not reflect their hazards, populations or institutions.

Corporate research is concentrated. UNCTAD reports that 100 firms account for 40 per cent of global corporate research and development spending 8. Public research systems, shared facilities and open data are the main ways other countries and smaller organisations gain access to testing at scale.

Shared infrastructure helps. Open registries 10, open data policies 18 and testing facilities open to all providers 19 let more researchers design, run and check experiments. Training in study design and statistics multiplies the value of each facility.

Capacity is also cultural. The reproducibility manifesto argues that incentives must change so that rigorous, transparent and reproducible research is rewarded 14. The Global Risks Forum topic on collaborative research covers how research networks share capacity across borders.

12증거

How experimental research is measured

Indicators of capacity, openness and reliability, and their limits.

Evidence on the discipline comes from four families of data. Statistics on research spending and researchers measure capacity. Registries count trials and protocols. Replication projects and surveys test reliability. Innovation indices compare how economies turn research into results.

Capacity indicators are official. Research and development spending as a share of GDP and researchers per million people are Sustainable Development Goal indicators reported by the UN 1. The World Intellectual Property Organization's Global Innovation Index 2025, its 18th edition, measures innovation performance across around 140 economies 22.

Registry counts show the scale of planned research 12, and replication projects show how often findings hold 2. Neither alone measures quality: a registered trial can still be poorly designed, and one failed replication does not show that an original finding was false.

The limits are important. Spending figures say nothing about what was learned. Replication rates differ widely across fields and methods. Survey responses reflect perceptions. Sound analysis states which indicator supports each claim and does not stretch it.

측정 대상지표Latest valuePublished by
Research investmentR&D expenditure as a share of global GDP1.95 per cent, 2022 1국제연합
Research workforceResearchers per million people, world1,420, 2022 1국제연합
Regional gapResearchers per million people, sub-Saharan Africa91 1국제연합
집중도Share of corporate R&D by 100 firms40 per cent 8UNCTAD
Trial registrationStudies registered on ClinicalTrials.gov612,025, November 2026 12U.S. National Library of Medicine
Peer review before resultsJournals offering Registered ReportsOver 300 4Center for Open Science
ReplicationPsychology replications with statistically significant results36 per cent of replications significant, 2015 2Open Science Collaboration
Table 1. Selected indicators of research capacity, openness and reliability, the latest value found and the body that publishes it, as of 16 November 2026.

13무결성

Ethics, integrity and safety in experiments

Protecting participants, the public and the record.

Experiments involving people carry duties. The Declaration of Helsinki sets ethical principles for medical research involving human participants, including registration before recruitment 3. WHO published guidance for best practices for clinical trials in September 2024 23.

Integrity covers honesty in every step. The European Code of Conduct for Research Integrity, revised in 2023, was updated to remain fit for all disciplines and emerging areas of research, with greater weight on research culture 24. In the United Kingdom, institutions eligible for Research England funding must implement the Concordat to Support Research Integrity as a condition of funding 25.

Safety extends to the public and the environment. Testbeds and field trials must contain failures, protect bystanders and data, and stop when risks exceed what was agreed. The AI Act requires that significant risks found in a sandbox be mitigated or, failing that, that development and testing be suspended 6.

The Global Risks Forum topic on research integrity covers the institutions that oversee these duties.

14수단

The instruments that shape experimental research

Declarations, laws, policies, codes and frameworks, and their status.

Ethical declarations set the baseline for research with people. The Declaration of Helsinki was last amended in October 2024 3. WHO's registry platform and data set establish the global norm for trial registration 1011.

Law turns norms into duties. The EU Clinical Trials Regulation requires registration before a trial starts 13. The AI Act requires national AI regulatory sandboxes and excludes pure research from its scope 6.

Funders and academies shape practice. The NIH data sharing policy requires data management plans 18. The European Code of Conduct for Research Integrity 24 and the UK Concordat 25 set expectations for institutions.

Technical frameworks support testing. NASA's Technology Readiness Levels describe maturity 5, NIST's AI Risk Management Framework structures the management of AI risk 21, and the FAIR principles define what makes data reusable 16.

도구Issuer상태기능
Declaration of Helsinki 3World Medical AssociationAmended October 2024Ethical principles; registration before recruitment
International Clinical Trials Registry Platform 10WHO운영Global network of trial registries
Regulation (EU) No 536/2014 13유럽연합In forceClinical trials registered before start
AI Act, regulatory sandboxes 6유럽연합In forceAt least one national AI sandbox per Member State
NIH Data Management and Sharing Policy 18National Institutes of HealthEffective January 2023Data management and sharing plans
유럽 연구윤리 행동강령 24ALLEARevised 2023Standards of research integrity
AI Risk Management Framework 1.0 21NISTReleased January 2023Managing risks of AI systems
Technology Readiness Levels 5NASAIn useNine levels of technology maturity
Table 2. Instruments that shape experimental research and testbeds, and their status as of 16 November 2026.

15Frontiers

What is changing in the discipline

Five areas where methods and practice are moving fastest.

Peer review before results. More than 300 journals offering Registered Reports 4 shift attention from striking results to sound questions and methods.

AI inside the experiment. Where AI tools enter research design and analysis, the same question applies as to any method: can the result be tested? The NIST AI Risk Management Framework gives a structure for managing AI risk 21.

Regulatory sandboxes by law. The AI Act's requirement for national sandboxes 6 makes supervised experimentation a standard step for a whole class of technology.

Shared testing infrastructure. Large reference sites such as the EU's AI testing and experimentation facilities 19 lower the cost of testing at scale.

Data sharing as a condition of funding. The NIH data sharing policy ties data management and sharing plans to funding applications 18, and the FAIR principles set out what makes data reusable 16.

16컨소시엄

Three faces of experimental research across the Consortium

Science, governance and finance for the same evidence.

The same trial looks different to the scientist who designs it, to the body that governs research and to the actuary who prices the risk it measures. Within the Consortium, The Global Centre for Risk and Innovation (GCRI) leads on science and methods through the Labs platform, its STEM foundation and the canonical method pages on statistics, causal analysis and uncertainty quantification.

The Global Risks Forum (GRF) leads on governance and cooperation. Its Research platform covers research governance and the science-policy interface, and its Innovation platform covers innovation governance, including responsible innovation.

The Global Risks Alliance (GRA) translates evidence into the questions finance asks, without lending, underwriting or rating. Its Actuarial Science and Quantitative Risk platform asks how evidence becomes loss models, including its topic on credibility and sparse data.

Work moves between the three in a cycle: a question is stated, evidence is assembled, an experiment is built and tested, findings are published, competent authorities decide, and lessons reset the next cycle. The counterparts page lists the matching platforms, and the field gateways for research subjects, methods and innovation subjects show the same subjects across all three faces.

What this article does not claim: it explains a discipline and the public evidence on it. It is not ethical approval, regulatory advice or a protocol for any specific study, and it does not assess any trial, laboratory or testbed. Figures describe the samples and years stated. GCRI does not regulate or certify, GRF does not regulate or finance, and GRA does not lend, underwrite or rate. Naming an organisation, framework or facility is not a claim of partnership, endorsement or deployment.

17주제

Explore the Labs topics

The eight foundational topics of the platform, each with its own article.

This article is the hub for eight foundational topic articles. Research protocols covers how studies are planned; field and lab testbeds covers controlled test environments; AI and scientific workflows covers AI inside research; and reproducibility and negative results covers reliability.

Four topics apply the methods to future-facing labs: the future of work lab, the future of media lab, the future of energy and water labs and the future of health and bio labs. The Climate and Hazards platform's pillar on climate science and natural hazards shows how observation, models and tests combine in one field.

질문

질문과 답변

What is a testbed?

A controlled environment, physical, digital or hybrid, where a technology, policy or service is tried at realistic scale before release, so that its behaviour can be measured while risks are contained.

What is the difference between reproducibility and replicability?

Reproducibility means getting the same result from the same data and code; replicability means getting consistent results from a new study of the same question. The National Academies set out these definitions in 2019 7.

Why do some research findings fail to replicate?

Small samples, small effects, flexible analysis and selective publication all raise the chance of false positives 9. A large replication of 100 psychology experiments found statistically significant results in 36 per cent of the replications 2.

What is pre-registration?

Recording a study's question, design and analysis plan in a public registry before data are collected. Medical research with human participants must be registered before the first participant is recruited 3.

What is a regulatory sandbox?

A supervised arrangement in which new products or services are tested under a regulator's oversight. Under the EU AI Act each Member State must establish at least one AI regulatory sandbox 6.

What are technology readiness levels?

A scale of nine levels, from TRL 1 to TRL 9, used by NASA and others to assess the maturity of a technology 5.

What does FAIR data mean?

Data that are Findable, Accessible, Interoperable and Reusable by people and machines, following guiding principles published in Scientific Data in 2016 16.

약관

용어집

Experiment
A study that changes one or more factors on purpose and measures what follows.
프로토콜
The written plan of a study, set down before data are collected.
테스트베드
A controlled environment where a technology or service is tried at realistic scale.
Replication
A new study of the same question to test whether a finding holds.
Pre-registration
Public recording of a study plan before data collection.
Regulatory sandbox
A supervised arrangement for testing new products under a regulator's oversight.
기술 성숙도 수준
One of nine steps describing the maturity of a technology.
FAIR data
Data that are Findable, Accessible, Interoperable and Reusable.

Reuse and cite

Text CC BY 4.0. Cite the page with its date; data tables are linked under each figure.

출처

참고문헌

25 sources, numbered in the order they are first cited
  1. United Nations Statistics Division (2025 edition). The Sustainable Development Goals Report 2025: Goal 9, Industry, innovation and infrastructure. unstats.un.org. Accessed 2026-11-16.
  2. Open Science Collaboration, Science (2015-08-28). Estimating the reproducibility of psychological science. doi.org. Accessed 2026-11-16.
  3. World Medical Association (Amended by the 75th WMA General Assembly, Helsinki, October 2024). WMA Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Participants. www.wma.net. Accessed 2026-11-16.
  4. Center for Open Science (COS page, current as of 16 November 2026). Registered Reports. www.cos.io. Accessed 2026-11-16.
  5. National Aeronautics and Space Administration (NASA page, current as of 16 November 2026). Technology Readiness Levels. www.nasa.gov. Accessed 2026-11-16.
  6. European Union, EUR-Lex (2024-06-13). Regulation (EU) 2024/1689 (Artificial Intelligence Act): AI regulatory sandboxes. eur-lex.europa.eu. Accessed 2026-11-16.
  7. National Academies of Sciences, Engineering, and Medicine (Consensus Study Report, 2019). Reproducibility and Replicability in Science (Consensus Study Report). nap.nationalacademies.org. Accessed 2026-11-16.
  8. UN Trade and Development (UNCTAD) (2025-04-07). AI's $4.8 trillion future: UN Trade and Development alerts on divides, urges action (Technology and Innovation Report 2025). unctad.org. Accessed 2026-11-16.
  9. Ioannidis J.P.A., PLoS Medicine (2005-08-30). Why Most Published Research Findings Are False. doi.org. Accessed 2026-11-16.
  10. World Health Organization (WHO page, current as of 16 November 2026). International Clinical Trials Registry Platform (ICTRP). www.who.int. Accessed 2026-11-16.
  11. World Health Organization (WHO page, current as of 16 November 2026). WHO Trial Registration Data Set. www.who.int. Accessed 2026-11-16.
  12. U.S. National Library of Medicine, ClinicalTrials.gov (2026-11-16). ClinicalTrials.gov API: total registered studies. clinicaltrials.gov. Accessed 2026-11-16.
  13. European Union, EUR-Lex (2014-04-16). Regulation (EU) No 536/2014 on clinical trials on medicinal products for human use. eur-lex.europa.eu. Accessed 2026-11-16.
  14. Munafò M.R. et al., Nature Human Behaviour (2017-01-10). A manifesto for reproducible science. doi.org. Accessed 2026-11-16.
  15. National Institutes of Health (Web page with scope note). Enhancing Reproducibility through Rigor and Transparency. grants.nih.gov. Accessed 2026-11-17.
  16. Wilkinson M.D. et al., Scientific Data (2016-03-15). The FAIR Guiding Principles for scientific data management and stewardship. doi.org. Accessed 2026-11-16.
  17. GO FAIR (GO FAIR page, current as of 16 November 2026). FAIR Principles. www.go-fair.org. Accessed 2026-11-16.
  18. National Institutes of Health (2023-01-25). NIH Data Management and Sharing Policy: overview. grants.nih.gov. Accessed 2026-11-16.
  19. European Commission (Commission page, current as of 16 November 2026). Sectorial AI Testing and Experimentation Facilities under the Digital Europe Programme. digital-strategy.ec.europa.eu. Accessed 2026-11-16.
  20. Financial Conduct Authority (UK) (FCA page, last updated 28 October 2026). Regulatory Sandbox. www.fca.org.uk. Accessed 2026-11-16.
  21. National Institute of Standards and Technology (2023-01-26). AI Risk Management Framework (AI RMF 1.0). www.nist.gov. Accessed 2026-11-16.
  22. World Intellectual Property Organization (2025 edition, 18th). Global Innovation Index 2025. www.wipo.int. Accessed 2026-11-16.
  23. World Health Organization (2024-09-25). Guidance for best practices for clinical trials. www.who.int. Accessed 2026-11-16.
  24. ALLEA (All European Academies) (Revised edition 2023). The European Code of Conduct for Research Integrity, revised edition 2023. allea.org. Accessed 2026-11-16.
  25. UK Research and Innovation (UKRI page, current as of 16 November 2026). Research integrity (Good research resource hub). www.ukri.org. Accessed 2026-11-16.

기록

Editorial record

Facts and policies are stated as of 16 November 2026. This article is reviewed at least every 180 days and whenever a cited report, policy or instrument changes, including the next SDG report on research capacity and any guidance issued under the AI Act on regulatory sandboxes.

Published by the GCRI editorial desk for the Labs platform under the editorial integrity policy. To report an error or request a correction, use the corrections and concerns route; corrections are dated and listed with the article.

Text is published under the Creative Commons Attribution 4.0 licence (CC BY 4.0): reuse it with credit to GCRI and a link to this page. Third-party data keep their own terms.

Cite this article

GCRI editorial desk (2026, November 16). Experimental research methods and testbeds explained. Labs. https://therisk.global/nexus-labs/experimental-research-methods-and-testbeds/

Republish

Republish or translate this article free of charge, in print or online, under CC BY 4.0: keep the byline and Labs, link to the original and note any change. Figures, maps and twins made by the institutions carry the same licence; third-party data keeps its own credit line.

Attribution to paste
<p>Experimental research methods and testbeds: the foundations of a discipline — GCRI editorial desk, Labs. First published 16 November 2026 at <a href="https://therisk.global/nexus-labs/experimental-research-methods-and-testbeds/">https://therisk.global/nexus-labs/experimental-research-methods-and-testbeds/</a>. Republished under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/).</p>

Related across the Consortium

비중

EmailLinkedInBlueskyMastodon

The Global Centre for Risk and Innovation (GCRI Canada) is a Canadian not-for-profit organisation, not a registered charity, with its registered office in Ontario.